These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


354 related items for PubMed ID: 17995529

  • 21. Plasmin and sodium retention in nephrotic syndrome.
    Kleyman TR, Hughey RP.
    J Am Soc Nephrol; 2009 Feb; 20(2):233-4. PubMed ID: 19176698
    [No Abstract] [Full Text] [Related]

  • 22. Pathogenesis of edema formation in the nephrotic syndrome.
    Donckerwolcke RA, Vande Walle JG.
    Kidney Int Suppl; 1997 Mar; 58():S72-4. PubMed ID: 9067949
    [No Abstract] [Full Text] [Related]

  • 23. The interaction of pendrin and the epithelial sodium channel in blood pressure regulation.
    Wall SM, Pech V.
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):18-24. PubMed ID: 18090665
    [Abstract] [Full Text] [Related]

  • 24. Role of sodium during formation of edema in children with nephrotic syndrome.
    Gurgoze MK, Gunduz Z, Poyrazoglu MH, Dursun I, Uzum K, Dusunsel R.
    Pediatr Int; 2011 Feb; 53(1):50-6. PubMed ID: 20573038
    [Abstract] [Full Text] [Related]

  • 25. A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome.
    Schrier RW, Fassett RG.
    Kidney Int; 1998 May; 53(5):1111-7. PubMed ID: 9573524
    [Abstract] [Full Text] [Related]

  • 26. Perspectives on edema in childhood nephrotic syndrome.
    Teoh CW, Robinson LA, Noone D.
    Am J Physiol Renal Physiol; 2015 Oct 01; 309(7):F575-82. PubMed ID: 26290369
    [Abstract] [Full Text] [Related]

  • 27. Renal handling of sodium in the nephrotic syndrome.
    Perico N, Remuzzi G.
    Am J Nephrol; 1993 Oct 01; 13(5):413-21. PubMed ID: 8116693
    [Abstract] [Full Text] [Related]

  • 28. [Role of aldosterone in the development of edema].
    Dorhout Mees EJ, Koomans HA.
    Nephrologie; 1985 Oct 01; 6(3):123-6. PubMed ID: 4080071
    [Abstract] [Full Text] [Related]

  • 29. [Physiopathology and treatment of nephrotic syndrome complications].
    Ducloux D.
    Nephrol Ther; 2011 Feb 01; 7(1):52-7. PubMed ID: 20395187
    [Abstract] [Full Text] [Related]

  • 30. Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease.
    Vande Walle JG, Donckerwolcke RA, Koomans HA.
    J Am Soc Nephrol; 1999 Feb 01; 10(2):323-31. PubMed ID: 10215332
    [Abstract] [Full Text] [Related]

  • 31. Intra- and extrarenal factors of oedema formation in the nephrotic syndrome.
    Tulassay T, Rascher W, Schärer K.
    Pediatr Nephrol; 1989 Jan 01; 3(1):92-100. PubMed ID: 2702097
    [Abstract] [Full Text] [Related]

  • 32. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
    Mall MA.
    Exp Physiol; 2009 Feb 01; 94(2):171-4. PubMed ID: 19060118
    [Abstract] [Full Text] [Related]

  • 33. Plasma kallikrein activates the epithelial sodium channel in vitro but is not essential for volume retention in nephrotic mice.
    Haerteis S, Schork A, Dörffel T, Bohnert BN, Nacken R, Wörn M, Xiao M, Essigke D, Janessa A, Schmaier AH, Feener EP, Häring HU, Bertog M, Korbmacher C, Artunc F.
    Acta Physiol (Oxf); 2018 Sep 01; 224(1):e13060. PubMed ID: 29489063
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Rodent models to study sodium retention in experimental nephrotic syndrome.
    Xiao M, Bohnert BN, Grahammer F, Artunc F.
    Acta Physiol (Oxf); 2022 Jul 01; 235(3):e13844. PubMed ID: 35569011
    [Abstract] [Full Text] [Related]

  • 37. Proteasuria-The impact of active urinary proteases on sodium retention in nephrotic syndrome.
    Artunc F, Wörn M, Schork A, Bohnert BN.
    Acta Physiol (Oxf); 2019 Apr 01; 225(4):e13249. PubMed ID: 30597733
    [Abstract] [Full Text] [Related]

  • 38. Edema of the nephrotic syndrome: the role of the atrial peptide system.
    Perico N, Remuzzi G.
    Am J Kidney Dis; 1993 Sep 01; 22(3):355-66. PubMed ID: 8372830
    [Abstract] [Full Text] [Related]

  • 39. Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar.
    Spraggs C, McCarthy A, McCarthy L, Hong G, Hughes A, Lin X, Sathe G, Smart D, Traini C, Van Horn S, Warren L, Mosteller M.
    Pharmacogenet Genomics; 2007 Dec 01; 17(12):1065-76. PubMed ID: 18004211
    [Abstract] [Full Text] [Related]

  • 40. Time-course of sodium transport along the nephron in nephrotic syndrome: The role of potassium.
    Dizin E, Olivier V, Maire C, Komarynets O, Sassi A, Roth I, Loffing J, de Seigneux S, Maillard M, Rutkowski JM, Edwards A, Feraille E.
    FASEB J; 2020 Feb 01; 34(2):2408-2424. PubMed ID: 31908015
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.